Found 1 publication.
Displayed publication 1
Expand all publications
Collapse all publications
Show all as text (SweetDB notation)
Show all graphically (SNFG notation)
1. (Article ID: 5341)
Ben-Menachem G, Kubler-Kielb J, Coxon B, Yergey A, Schneerson R
A newly discovered cholesteryl galactoside from Borrelia burgdorferi
Proceedings of the National Academy of Sciences of the USA 100(13) (2003)
7913-7918
Two major glycolipids, which comprise ≈36% of the total lipid mass from Borrelia burgdorferi, the etiological agent of Lyme disease, were investigated. We determined the fatty acid type, sugar identity, anomeric configuration, and substituent type and position. The structures were identified as cholesteryl 6-O-acyl-β-d-galactopyranoside (B. burgdorferi glycolipid 1, BbGL-I), and 1,2-di-O-acyl-3-O-α-d-galactopyranosyl-sn-glycerol (BbGL-II). The major fatty acids were palmitate and oleate. The structures were corroborated by gas-liquid chromatography MS, matrix-assisted laser desorption/ionization time-of-flight spectroscopy, fast atom bombardment MS, detailed NMR spectrometry, and metabolic labeling. This is a previously undescribed demonstration of a cholesteryl galactoside in bacteria. Lipopolysaccharide was not detected in B. burgdorferi. The two glycolipids have several properties suggesting they may function as lipopolysaccharide: both are main components of the bacterial membrane, surface exposed, and have a three-domain structure. BbGL-I elicited specific antibodies in mice and rabbits, and BbGL-II elicited antibodies that reacted with both glycolipids.
glycolipid, Borrelia burgdorferi, Lyme disease, galactoside
NCBI PubMed ID: 12799465Publication DOI: 10.1073/pnas.1232451100Journal NLM ID: 7505876Publisher: National Academy of Sciences
Correspondence: Ben-Menachem G
nih.gov>
Institutions: Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland, Laboratory of Developmental and Molecular Immunity, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, USA, Laboratory of Cellular and Molecular Biophysics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, USA
Methods: 13C NMR, 1H NMR, methylation, GLC-MS, deacetylation, NMR-2D, FAB-MS, TLC, MALDI-TOF MS, biological assays, radiolabeling, enzymatic digestion, extraction, affinity chromatography, acetylation, methylation analysis, reduction, hydrolysis, CC, cell growth, derivatization, evaporation, centrifugation
The publication contains the following compound(s):
- Compound ID: 13444
|
/Variants 0/-a-D-Galp-(1-3)-Subst
/Variants 0/ is:
Pam-(1-6)-
OR (exclusively)
Ole-(1-6)-
Subst = cholesterol = SMILES C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC{3}[C@@H](C4)O)C)C |
Show graphically |
Structure type: monomer
; 809.87-835.87 [M+Na]+
Compound class: glycolipid, glycoside
- Compound ID: 13445
|
/Variants 0/-a-D-Galp2Ac3Ac4Ac-(1-3)-Subst
/Variants 0/ is:
Pam-(1-6)-
OR (exclusively)
Ole-(1-6)-
Subst = cholesterol = SMILES C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC{3}[C@@H](C4)O)C)C |
Show graphically |
Structure type: monomer
; 935.7-961.7 [M+Na]+
Compound class: glycolipid, glycoside
- Compound ID: 13446
|
/Variants 0/-+
|
a-D-Galp-(1-1)-D-Gro-(2-1)-Pam
/Variants 0/ is:
Pam-(1-3)-
OR (exclusively)
Ole-(1-3)- |
Show graphically |
Structure type: monomer
; 780.1-806.1 [M+Na]+
Compound class: glycolipid
- Compound ID: 13447
|
/Variants 0/-+
|
a-D-Galp2Ac3Ac4Ac6Ac-(1-1)-D-Gro-(2-1)-Pam
/Variants 0/ is:
Pam-(1-3)-
OR (exclusively)
Ole-(1-3)- |
Show graphically |
Structure type: monomer
Compound class: glycolipid
Expand this publication
Collapse this publication
Total list of publication IDs on all result pages of the current query:
Total list of corresponding CSDB IDs (permanent record IDs):
Execution: <1 sec